Urgo Medical  

• Continuous, consistent and comfortable therapeutic pressure delivered day and night

UrgoK2™ is for the treatment of venous leg ulcers, venous edema and lymphedema, which require full compression.

Arterial conditions (arterial or predominantly arterial ulcers; known or suspected arterial disease).
Ankle-brachial Index (ABI) <0.8.
Patients suffering from diabetic microangiopathy, ischemic phlbitis (phlegmatia coerulea dolens), septic thrombosis.
Ulceration caused by infection.
Allergy to any of the components.

Check that the ABI >0.8 before prescribing the bandage system.
In the event of diabetes, heart failure or advanced micro-vascular disease, use the compression system with close medical monitoring following appropriate treatment.
In case of infected peri-ulcer dermatitis, treat infection before commencing compression bandage therapy.
In case of an ulcer from a rare origin (vasculitis, hemopathy, pyoderma gangrenosum, etc.) the compression system should only be used following specialist referral.
The efficacy of UrgoK2™ has been tested and validated for the application KTECH and KPRESS together.
The PresSure system has been specifically designed to aid application of the bandages; it is important to follow the instructions carefully to achieve the recommended therapeutic pressure.
If you have any concern, especially in case of pain whilst wearing the compression system, contact your doctor or clinician.
Any serious incident linked to the product has to be reported to the manufacturer.

Store away from light and heat.

• Draws exudate away from the wound surface
• Removes toxic components such as slough, wound debris and bacteria that compromise wound healing
• Vertical and horizontal exudate dispersion controls and retains wound fluid so that it can be transferred to additional dressing layers if needed
• Available in tracheostomy dressing

Drawtex® may be used for: venous, neuropathic foot and pressure ulcers; burns and dehisced surgical wounds; stoma sites; amputations; difficult-to-heal wounds such as mixed etiology leg ulcers, leprosy-related wounds, necrotizing fasciitis, cavity wounds, chronic wounds with slough, clinically infected wounds, fungating cancer wounds and Buruli ulcers.

Contraindicated for use on wounds with arterial bleeding.

A non-adherent wound contact layer such as UrgoTul™ or UrgoTul™ Ag should be used on burns as well as low-exuding wounds to prevent adherence to the wound bed.

• Provides silver sulfate to assist in providing an antimicrobial barrier paired with the ideal moist wound environment

UrgoTul™ Ag is for use on acute and chronic wounds or wounds with signs of clinical infection.

Contraindicated for use with HBOT.

Should not be used on individuals who are sensitive to silver or who have had allergic reactions to the dressings or one of its components.

To be stored below 30°C (86°F).

Silver sulfate

Polyester mesh and the TLC™ Restoring Matrix, lipidocolloid coating

• The only wound interface with the added benefit of hydrophilic particles, ensuring the ideal moist environment for key cells in the healing process
• Contains hydrophobic substances as well to avoid adherence upon removal
• Has the ability to retain its coating over a significant time period

UrgoTul™ is indicated for use on acute and chronic wounds.

Contraindicated for use with HBOT.

To be stored below 30°C (86°F).

Polyester mesh and lipidocolloid coating

• Draws exudate away from the wound surface
• Removes toxic components such as slough, wound debris and bacteria that compromise wound healing
• Vertical and horizontal exudate dispersion controls and retains wound fluid so that it can be transferred to additional dressing layers if needed